WBSCR16 Inhibitors
WBSCR16 inhibitors are a chemical class of compounds that target the WBSCR16 protein, which is a part of the complex molecular machinery within cells. The WBSCR16 protein, also known as Williams Beuren syndrome chromosome region 16, is implicated in various cellular processes due to its role in the assembly of ribosomes-the cellular structures responsible for protein synthesis. Ribosomes are essential for the translation of genetic information into functional proteins, a critical step in maintaining the normal operation of cellular activities. By inhibiting WBSCR16, these compounds interfere with the formation of ribosomes, which can have a significant impact on the rate and regulation of protein synthesis within the cell. The precise molecular mechanism by which WBSCR16 inhibitors exert their effects involves binding to the WBSCR16 protein, thereby blocking its function and disrupting the normal ribosomal biogenesis pathway.
The development and study of WBSCR16 inhibitors have provided insights into the fundamental biological processes governing cell growth and proliferation. The inhibition of WBSCR16 is associated with alterations in the cellular homeostasis, as proteins play vital roles in almost all cellular functions, from structural support to the catalysis of biochemical reactions. Since WBSCR16 is involved in the maturation of the 40S ribosomal subunit, substances that inhibit its action can cause a cascade of effects on the cell's ability to produce proteins. Research into WBSCR16 and its inhibitors has expanded our understanding of ribosomal biogenesis and its regulation, revealing the complex interplay between various genetic and molecular factors. This research has been critical in elucidating the detailed pathways and interactions that govern cellular function at the molecular level, providing a foundation for a deeper understanding of the intricate web of life at the smallest scales.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that disrupts the mTORC1 complex, leading to the inhibition of downstream signaling pathways that are critical for protein synthesis and cell growth. As WBSCR16 is involved in ribosome biogenesis and function, the inhibition of mTORC1 would likely result in decreased functional activity of WBSCR16 due to reduced ribosome production and function. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin is an HMG-CoA reductase inhibitor that leads to decreased cholesterol synthesis. By limiting the availability of crucial isoprenoid intermediates, simvastatin indirectly impacts protein prenylation which is essential for membrane localization and function of certain proteins. If WBSCR16 requires prenylation for its activity, simvastatin could indirectly inhibit its function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to heat shock protein 90 (Hsp90), inhibiting its chaperone activity. As Hsp90 is involved in stabilizing a wide array of client proteins, its inhibition could affect the proper folding and stability of WBSCR16, leading to its functional inhibition. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a protein synthesis inhibitor that acts by blocking the translocation step in protein elongation. As WBSCR16 is involved in protein synthesis through its role in ribosome biogenesis, cycloheximide would block the synthesis of new WBSCR16 protein molecules, leading to decreased functional activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the function of the Golgi apparatus by blocking protein transport from the ER to the Golgi. If WBSCR16 trafficking or function relies on Golgi-mediated processing, Brefeldin A could indirectly inhibit WBSCR16 by disrupting its proper localization and maturation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that blocks the PI3K/AKT/mTOR signaling pathway. This pathway is involved in various cellular processes including cell growth and proliferation. Inhibition of this pathway could lead to a reduction in ribosome biogenesis and function, potentially inhibiting the functional activity of WBSCR16. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is an autophagy inhibitor that prevents the fusion of autophagosomes with lysosomes. Inhibition of autophagy could lead to increased cellular stress and potentially disrupt the processes in which WBSCR16 is involved, such as ribosome biogenesis and function. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, preventing RNA synthesis. By inhibiting rRNA transcription, it would directly affect ribosome biogenesis, which is a process in which WBSCR16 is implicated, hence potentially decreasing WBSCR16's functional activity. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits the export of proteins from the nucleus by binding to Exportin 1 (CRM1). If the function of WBSCR16 is linked to its nuclear-cytoplasmic transport, Leptomycin B could impede its proper localization and thereby inhibit its function. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA. This would inhibit global protein synthesis, including the synthesis of WBSCR16, thereby reducing its activity. | ||||||